Invention Grant
- Patent Title: Anti-LILRB antibodies and their use in detecting and treating cancer
-
Application No.: US16678049Application Date: 2019-11-08
-
Publication No.: US11498963B2Publication Date: 2022-11-15
- Inventor: Chengcheng Zhang , Mi Deng , Wei Xiong , Zhiqiang An , Ningyan Zhang , Xun Gui , Junke Zheng
- Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; G01N33/574 ; C12N15/113 ; A61P35/02 ; A61K39/395 ; A61K45/06 ; C07K16/30
Abstract:
The present disclosure is directed to antibodies binding to LILRBs and methods of detecting and treating cancer therewith.
Public/Granted literature
- US20200079851A1 ANTI-LILRB ANTIBODIES AND THEIR USE IN DETECTING AND TREATING CANCER Public/Granted day:2020-03-12
Information query
